![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/compugen-reports-second-quarter-2024-results-302215329.html
https://www.prnewswire.com/news-releases/compugen-to-present-at-upcoming-antibody-industrial-symposium-302174100.html
https://endpts.com/compugen-nxera-disclose-milestone-payments-insmed-aims-for-650m-offering/
https://www.prnewswire.com/news-releases/compugen-to-receive-milestone-payment-triggered-by-dosing-of-first-patient-in-the-second-phase-3-trial-evaluating-rilvegostomig-302159115.html
https://www.prnewswire.com/news-releases/compugen-reports-first-quarter-2024-results-302149941.html
https://www.prnewswire.com/news-releases/compugen-publishes-paper-in-cancer-immunology-research-on-unique-biology-of-pvrig-and-its-therapeutic-potential-302147507.html
https://www.prnewswire.com/news-releases/compugen-appoints-david-silberman-as-chief-financial-officer-302146086.html
https://www.prnewswire.com/news-releases/compugen-to-release-first-quarter-2024-results-on-monday-may-20-2024-302136627.html
https://www.prnewswire.com/news-releases/compugen-to-present-new-clinical-data-showing-com701-triple-combination-preliminary-anti-tumor-activity-in-microsatellite-stable-colorectal-cancer-with-liver-metastases-at-asco-2024-302127186.html
https://www.prnewswire.com/news-releases/compugen-publishes-paper-in-cancer-immunology-research-demonstrating-therapeutic-potential-of-com503-302112780.html